Variant report
Variant | esv2543561 |
---|---|
Chromosome Location | chr12:86014722-86016009 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528050934 | chr12:86014742-86014743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538886143 | chr12:86014770-86014771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531996785 | chr12:86014823-86014824 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554339779 | chr12:86014845-86014846 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183291407 | chr12:86014848-86014849 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546621593 | chr12:86014912-86014913 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12304956 | chr12:86014952-86014953 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536935686 | chr12:86014959-86014960 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139105380 | chr12:86015012-86015013 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576474019 | chr12:86015016-86015017 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537543775 | chr12:86015026-86015027 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559051623 | chr12:86015107-86015108 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542030494 | chr12:86015262-86015263 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540898891 | chr12:86015266-86015267 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559487490 | chr12:86015314-86015315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149892766 | chr12:86015386-86015387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7308482 | chr12:86015447-86015448 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs2199513 | chr12:86015469-86015470 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs530385994 | chr12:86015474-86015475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144048471 | chr12:86015577-86015578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563884870 | chr12:86015606-86015607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369050759 | chr12:86015643-86015644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12578708 | chr12:86015652-86015653 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs111685665 | chr12:86015655-86015656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547708835 | chr12:86015679-86015680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566229789 | chr12:86015748-86015749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536562401 | chr12:86015770-86015771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78161260 | chr12:86015784-86015785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75502186 | chr12:86015785-86015786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537491361 | chr12:86015850-86015851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558972226 | chr12:86015873-86015874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs117918690 | chr12:86015918-86015919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192110753 | chr12:86015922-86015923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182878920 | chr12:86015945-86015946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552914989 | chr12:86015966-86015967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115321536 | chr12:86016001-86016002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139914443 | chr12:86016009-86016010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:86011800-86014800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr12:86014600-86014800 | Enhancers | NHEK | skin |
3 | chr12:86014600-86015200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr12:86014600-86015400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr12:86014600-86015600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr12:86014600-86015600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr12:86014800-86015200 | Flanking Active TSS | NHEK | skin |
8 | chr12:86014800-86015400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr12:86014800-86015600 | Enhancers | HMEC | breast |
10 | chr12:86015200-86015600 | Enhancers | NHEK | skin |
11 | chr12:86015200-86020400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr12:86015400-86017000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr12:86015400-86017200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr12:86015600-86019600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr12:86015600-86019600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr12:86015600-86019600 | Weak transcription | HMEC | breast |
17 | chr12:86015600-86019800 | Weak transcription | NHEK | skin |